It has been a year of high-profile pharma exits in India. And after the recent departure of Roche’s India managing director, it’s now Cipla Ltd.’s global chief operating officer, R Ananthanarayanan, who is moving on.
Ananthanarayanan (Ananth to his close peers) took charge as COO in August 2018, coming with a broad remit covering several...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)

